🏥FY 2025 Supplemental Funding for National Suicide Prevention Lifeline
This notice is to inform the public that the Substance Abuse and Mental Health Services Administration (SAMHSA) is supporting a supplement (in scope of the parent award) for the Cooperative Agreement for National Suicide Prevention Lifeline and Disaster Distress Helpline recipient, Mental Health Association of New York City, Inc. (DBA Vibrant Emotional Health), funded in FY 2021 under Notice of Funding Opportunity (NOFO) SM 21-005. The recipient may receive up to $100,000,000 and has a project end date of September 2026. The supplemental funding will be used to maintain 988 operations and services, both at local levels and across all subnetwork services. This funding will ensure continuation of all 988 services and supports.
Learn More⚖️DEA Revocation of Registration
The Drug Enforcement Administration (DEA) revoked Ajumobi Agu, M.D.'s registration due to sustained illegal activity, including dispensing controlled substances without appropriate licenses. The order emphasizes the importance of compliance with both federal and state laws in the healthcare field, and the potential consequences for practitioners engaged in similar misconduct.
Learn More💊Medicaid and CHIP Information Collection Comment Request Overview
On May 28, 2010, the Office of Management and Budget (OMB) issued Paperwork Reduction Act (PRA) guidance related to the "generic" clearance process. Generally, this is an expedited process by which agencies may obtain OMB's approval of collection of information requests that are "usually voluntary, low-burden, and uncontroversial collections," do not raise any substantive or policy issues, and do not require policy or methodological review. The process requires the submission of an overarching plan that defines the scope of the individual collections that would fall under its umbrella. This Federal Register notice seeks public comment on one or more of our collection of information requests that we believe are generic and fall within the scope of the umbrella. Interested persons are invited to submit comments regarding our burden estimates or any other aspect of this collection of information, including: the necessity and utility of the proposed information collection for the proper performance of the agency's functions, the accuracy of the estimated burden, ways to enhance the quality, utility and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden.
Learn More⚖️Revocation of Medical Registration
The Drug Enforcement Administration issued an Order to Show Cause for the revocation of Dr. Henry-Norbert O. Ndekwe's registration due to his lack of authority to handle controlled substances in Oklahoma. The document outlines the legal processes regarding the revocation and highlights the implications for healthcare practitioners and businesses in the industry.
Learn More⚖️DEA Denies Moustafa Aboshady's Registration Application
The Drug Enforcement Administration (DEA) issued an Order to Show Cause, proposing the denial of Dr. Moustafa M. Aboshady's DEA registration application. The basis for this denial stems from his mandatory exclusion from Medicare, Medicaid, and all Federal health care programs due to previous legal convictions related to false statements in healthcare benefits programs. The Agency concluded that substantial evidence supported the denial of his application for registration.
Learn More⚖️DEA Suspends Dentist's Registration Over Compliance Violations
The Drug Enforcement Administration has issued an Order to Show Cause and suspended the registration of Lona Bibbs-Walker, D.D.S., citing inadequate records on controlled substances and lack of state authority to practice. The order illustrates critical compliance issues in the healthcare industry, emphasizing the importance of strict adherence to regulatory standards.
Learn More💊Key Medicare and Medicaid Regulatory Changes for 2026
This final rule revises the Medicare Advantage (Part C), Medicare Prescription Drug Benefit (Part D), Medicare cost plan, and Programs of All-Inclusive Care for the Elderly (PACE) regulations to implement changes related to prescription drug coverage, the Medicare Prescription Payment Plan, dual eligible special needs plans (D-SNPs), Part C and D Star Ratings, and other programmatic areas, including the Medicare Drug Price Negotiation Program. This final rule also codifies existing sub-regulatory guidance in the Part C and Part D programs.
Learn More🧪NIH Notice of Closed Meeting for Grant Review in Health Sector
The Department of Health and Human Services announces a closed meeting by the National Institute of Allergy and Infectious Diseases to evaluate grant applications. The session, scheduled for May 2025, emphasizes confidentiality of discussions regarding trade secrets and personal information. This review is aimed at advancing research on anti-infective and immune disease therapeutics.
Learn More🏥SSA Announces New Matching Program with IRS for Medicare Benefits
In accordance with the provisions of the Privacy Act, as amended, this notice announces a new matching program with the United States Department of the Treasury, Internal Revenue Service (IRS). Under this matching program, the IRS will disclose IRS to SSA certain return information for the purpose of verifying eligibility for the Medicare Part D Low Income Subsidy (LIS) and determines the correct subsidy percentage of benefits provided under the Social Security Act (Act).
Learn More💼New Social Security Matching Program
In accordance with the provisions of the Privacy Act, as amended, this notice announces a new matching program with the United Stated Department of Health and Human Services, Office of Child Support Services (OCSS). Under this matching program, OCSS will provide SSA with quarterly wage (QW) and unemployment insurance (UI) information located in the National Directory of New Hires (NDNH) to allow SSA to determine eligibility of applicants for Extra Help (low-income subsidy assistance) under the Medicare Prescription Drug, Improvement, and Modernization Act (MMA) of 2003. This agreement assists SSA in determining eligibility of applicants for Extra Help, redetermining eligibility of existing Extra Help beneficiaries during periodic screening, and administering the Extra Help program.
Learn More